Search Results 451-460 of 23764 for prostate cancer
... prostate cancer and acute nonlymphocytic leukemia (ANLL). It belongs to the group of medicines known as antineoplastics or cancer medicines. Mitoxantrone is ...
Proton therapy toxicity outcomes for localized prostate cancer: Long-term results at a comprehensive cancer center. Clin Transl Radiat Oncol. 2024 Sep; 48 ...
The purpose of this study is to determine how patients with metastatic castration-resistant prostate cancer, and evidence of a homologous recombination gene ...
Lung cancer is the leading cause of cancer deaths in the U.S. Lung cancer claims more lives each year than colon, prostate, ovarian and breast cancers combined.
... cancer, prostate cancer, kidney cancer and other urological conditions. Overview. The Department of Urology-Research at Mayo Clinic has a strong legacy of ...
Colorectal Cancer Model Finds Out-of-Tune T Cells. Mayo Clinic Staff. October 25, 2021. Research Tool Used in Prostate Cancer May Lead to New Therapies. Mayo ...
Also want to find out if kidney tumor treatment leads to an improvement in these immune markers. Imaging of Prostatic Anatomy in Patients with Known Prostate ...
Rochester, Minn. Many of the current imaging tests we have for prostate cancer are problematic in their ability to distinguish cancerous from non-cancerous ...
The HPV vaccine was made to prevent cervical cancer. But it can prevent cancers of the anus, penis, and mouth and throat as well. The vaccine also prevents ...
About this study. This is a single patient study of an investigational drug CPI-613 for treatment of metastatic prostate cancer. Participation eligibility.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.